These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29150316)

  • 1. Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study.
    Smith-Bernardin S; Rowe C; Behar E; Geier M; Washington S; Santos GM; Euren J; Martin J; Gleghorn A; Coffin PO
    J Subst Abuse Treat; 2018 Feb; 85():109-115. PubMed ID: 29150316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.
    Harris AH; Bowe T; Hagedorn H; Nevedal A; Finlay AK; Gidwani R; Rosen C; Kay C; Christopher M
    Addict Sci Clin Pract; 2016 Sep; 11(1):15. PubMed ID: 27633982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.
    Crits-Christoph P; Markell HM; Gibbons MB; Gallop R; Lundy C; Stringer M; Gastfriend DR
    J Subst Abuse Treat; 2016 Nov; 70():50-57. PubMed ID: 27692188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe opioid withdrawal precipitated by Vivitrol®.
    Wightman RS; Nelson LS; Lee JD; Fox LM; Smith SW
    Am J Emerg Med; 2018 Jun; 36(6):1128.e1-1128.e2. PubMed ID: 29605483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up.
    Crèvecoeur-MacPhail D; Cousins SJ; Denering L; Kim T; Rawson RA
    J Subst Abuse Treat; 2018 Feb; 85():105-108. PubMed ID: 29174308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone and acamprosate. Using new drugs for alcohol dependence.
    Tedeschi M
    Aust Fam Physician; 2001 May; 30(5):447-50. PubMed ID: 11432017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study.
    Busch AC; Denduluri M; Glass J; Hetzel S; Gugnani SP; Gassman M; Krahn D; Deyo B; Brown R
    Alcohol Clin Exp Res; 2017 Jul; 41(7):1352-1360. PubMed ID: 28605827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector.
    Abraham AJ; Roman PM
    J Stud Alcohol Drugs; 2010 May; 71(3):460-6. PubMed ID: 20409441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular extended-release naltrexone: current evidence.
    Gastfriend DR
    Ann N Y Acad Sci; 2011 Jan; 1216():144-66. PubMed ID: 21272018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.
    Ray LA; Bujarski S; Grodin E; Hartwell E; Green R; Venegas A; Lim AC; Gillis A; Miotto K
    Am J Drug Alcohol Abuse; 2019; 45(2):124-140. PubMed ID: 30373394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Santos D; Matheson T; Colfax G; Batki SL
    Addiction; 2018 Feb; 113(2):268-278. PubMed ID: 28734107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of drugs for alcohol use disorder in Norway 2004–16].
    Heldal AT; Skurtveit S; Lobmaier PPK; Vederhus JK; Bramness JG
    Tidsskr Nor Laegeforen; 2018 Nov; 138(18):. PubMed ID: 30421743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of injectable naltrexone in U.S. substance use disorder treatment programs.
    Aletraris L; Bond Edmond M; Roman PM
    J Stud Alcohol Drugs; 2015 Jan; 76(1):143-51. PubMed ID: 25486403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: Development and biological evaluation.
    Santos RA; Rae M; Dartora VFMC; Matos JKR; Camarini R; Lopes LB
    Int J Pharm; 2020 Jul; 585():119474. PubMed ID: 32473371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.
    Brodtkorb TH; Bell M; Irving AH; Laramée P
    CNS Drugs; 2016 Feb; 30(2):163-77. PubMed ID: 26879458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging approaches to managing alcohol dependence.
    Swift R
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More Treatments on Deck for Alcohol Use Disorder.
    Lyon J
    JAMA; 2017 Jun; 317(22):2267-2269. PubMed ID: 28538998
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.